NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in C3.ai, Inc. ("C3.ai" or the "Company") (NYSE: AI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of C3.ai investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 8, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid= ...

LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against C3.ai, Inc. (“C3.ai” or the “Company”) (NYSE: AI). IF YOU SUFFERED A LOSS ON YOUR C3.AI INVESTMENTS, CLICK HERE BEFORE OCTOBER 21, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About? The complaint filed alleges that, between February 26, 2025 and August 8, 2025, Defenda ...

Key Takeaways C3.ai's Q1 fiscal 2026 revenues fell 19% to $70.3M, hurt by softer license demand and leadership shifts.About 60 large-scale engagements and its Agentic AI platform highlight C3.ai's generative AI positioning.A new Strategic Integrator Program aims to expand adoption through systems integrators and OEM partners.C3.ai, Inc.’s (AI) first-quarter fiscal 2026 results may not have inspired confidence on the surface, but its positioning in the generative AI race tells a more nuanced story. During th ...

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of C3.ai, Inc. (NYSE: AI). Shareholders who purchased shares of AI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=169637&from=3 CLASS PERIOD: February 26, 2025 to Augus ...

Accessibility StatementSkip Navigation PHILADELPHIA, Sept. 29, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against C3.ai, Inc. (NYSE: AI) ("C3.ai" or the "Company") on behalf of investors who purchased or acquired shares during the period from February 26, 2025 through August 8, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or acquired C3.ai securities during the Class Period may, no later than October 21, 2025, seek to be ...

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of C3.ai, Inc. (NYSE: AI)?Did you purchase your shares between February 26, 2025 and August 8, 2025, inclusive?Did you lose money in your investment in C3.ai, Inc.?Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI) investors of an upcoming deadline involving a securities fraud class action lawsuit ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of C3.ai, Inc. (NYSE: AI). Shareholders who purchased shares of AI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=169608&from=4 CLAS ...

诉讼核心指控 - 企业人工智能软件公司C3ai及其高级管理层因涉嫌误导投资者关于公司财务健康状况和增长前景而成为集体诉讼的目标[1] - 诉讼指控公司违反了1934年证券交易法[1] - 诉讼核心在于公司对营收和增长潜力的预测过于乐观且不切实际[2] 指控的具体内容 - 公司被指控淡化了首席执行官Thomas M Siebel健康问题所带来的重大风险[2] - 原告方认为公司关于增长和盈利能力的公开声明不切实际且过度依赖于首席执行官的健康与表现[2] - 调查重点在于公司公开声明是否因未能充分披露CEO健康状况对达成交易和实现财务目标能力的影响而具有误导性[5] 股价与财务表现 - 诉讼焦点集中在C3ai于2025年8月8日发布财务公告后出现的股价大幅下跌[3] - 公司在当日披露的初步第一季度业绩未达预期并下调了整个财年的营收指引[3] - 公司将令人失望的业绩归因于新领导层下的重组以及Siebel的健康问题[3] - 在此消息发布后公司股价据称暴跌超过25%[3] 诉讼程序细节 - 诉讼旨在代表在指定类别期间（2025年2月26日至2025年8月8日）购买或收购C3ai证券的投资者[2][4] - 遭受重大损失并有兴趣担任首席原告的投资者必须在2025年10月21日前向法院提交动议[2][4]

CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of C3 AI's growth; notably, that its Chief Executive Officer health was having a significant impact on the Company's ability to close deals, that its management was unable or otherwise ineffectual in minimizing that impact, and that C3 AI would not be a ...

诉讼核心指控 - 诉讼指控C3ai公司及其部分高管违反了1934年证券交易法 [1] - 指控称被告制造了其拥有可靠财务预测信息的假象 同时淡化了首席执行官健康问题对公司盈利能力的风险 [4] - 诉讼指出公司关于增长 盈利潜力和预期利润率的乐观报告严重依赖于CEO的健康状况和效率 与实际情况不符 [4] 财务表现与市场反应 - C3ai公司于2025年8月8日公布了2026财年第一季度令人失望的初步财务业绩 并降低了整个2026财年的收入指引 [5] - 公司将销售业绩不佳和指引下调归因于新领导层的重组以及CEO的健康问题 [5] - 在此消息公布后 C3ai公司股价下跌超过25% [5] 公司业务 - C3ai公司是一家企业人工智能应用软件公司 [3]